Director of the Minimally Invasive Treatment Center
Chief Physician
Introduction
Professor He Jianyu is a renowned international expert in minimally invasive oncology with over 40 years of dedicated clinical experience. He holds a Ph.D. in Surgery from Shanghai Medical College of Fudan University and completed postdoctoral research at Imperial College London. As Director of the Minimally Invasive Treatment Center at Modern Cancer Hospital Guangzhou, he specializes in providing innovative solutions for advanced and complex cancer cases. His medical philosophy integrates both Eastern and Western medical approaches, emphasizing precision, patient autonomy, and ethical practice. He is proficient in applying chemotherapy, targeted therapy, immunotherapy, and advanced minimally invasive technologies to treat various malignant tumors, particularly excelling in complex late-stage cases deemed "inoperable" by conventional standards.
Medical Experience
Over 40 years of clinical oncology practice with thousands of surgical procedures performed
Expertise in chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies therapy
Advanced training in Western standardized cancer treatment protocols during postdoctoral research at Imperial College London (early 2000s)
Proficient in multiple minimally invasive techniques including:
Cryoablation (cryotherapy)
Radiofrequency ablation
Microwave ablation
Particle implantation (125 iodine particles)
Nanoknife technology
Interventional therapy
Specialization in complex and advanced metastatic tumor cases
Active promoter of Multidisciplinary Team (MDT) approach in cancer treatment
Integration of traditional Chinese medicine with modern oncology approaches
Research Areas
Effects of Akt inhibitors (Erufosine) on proliferation inhibition in gastric cancer cells
Low-dose cisplatin-induced apoptosis mechanisms in gastric cancer
Chemotherapy regimen optimization for advanced non-small cell lung cancer (Docetaxel + Oxaliplatin vs. Cisplatin)
DCF regimen (Docetaxel + Cisplatin + 5-Fluorouracil) efficacy in advanced gastric cancer
Lymphangiogenic factors and their correlation with colorectal cancer metastasis
Clinical characteristics and treatment principles of primitive neuroectodermal tumors of bone
Minimally invasive technology applications in complex and advanced tumor cases
